Outcomes and Safety of Direct Oral Anticoagulants (DOACs) versus Vitamin K Antagonists (VKAs) amongst Patients with Valvular Heart Disease (VHD): A Systematic Review and Meta-Analysis

Outcomes and Safety of Direct Oral Anticoagulants (DOACs) versus Vitamin K Antagonists (VKAs) amongst Patients with Valvular Heart Disease (VHD): A Systematic Review and Meta-Analysis

Background: Both valvular heart disease (VHD) and atrial fibrillation (AF) frequently coexist. AF is an important cause of arrhythmias with a definitive cardiovascular morbidity. The use of either vitamin K antagonists (VKAs/warfarin) or direct oral anticoagulants (DOACs) (also known as new oral ant...

Full description

Bibliographic Details
Main Authors: Ghanshyam Patel, Beshoy Iskandar, Nikhila Chelikam, Siddhant Jain, Vandit Vyas, Tanvi Singla, Lavanya Dondapati, Ali Bombaywala, Appala Suman Peela, Milan Khealani, Sindhu Mukesh, Hariprasad Reddy Korsapati, Aishwarya Reddy Korsapati, Henok Regassa, Nitesh Jain, Urvish Patel, Vikramaditya Samala Venkata
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Hearts
Subjects:
direct oral anticoagulants
valvular atrial fibrillation
bleeding
stroke
valve
vitamin K antagonist
Online Access:https://www.mdpi.com/2673-3846/4/3/8

Internet

https://www.mdpi.com/2673-3846/4/3/8

Similar Items